Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

336.28 -2.17 (-0.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
News headline image
Nasdaq Stumbles: Tech Sector Faces Reality Check Amid Valuation Concerns and Sector Rotation
The Nasdaq Composite (NASDAQ: IXIC) experienced back-to-back losses on November 11 and 12, 2025, signaling a significant recalibration in the financial markets. This downturn, primarily driven by... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Dow Jones Soars to Unprecedented Heights as Market Cheers Government Shutdown Resolution
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) has shattered previous records, closing at an all-time high of 48,254.82 today, marking a significant milestone for the... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Amgen Stock Extends Rally After-Hours As CEO Hypes New Cholesterol Drug Data On Jim Cramer’s Show ↗
Via Stocktwits
News headline image
Unprecedented Market Anomaly: Gold and Silver Soar as Dow Breaches 48,000 Amidst Inflationary Fears and Geopolitical Tensions
The financial markets are currently exhibiting an extraordinary and complex phenomenon: both traditional safe-haven assets, gold and silver, are experiencing robust rallies, while the Dow Jones... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Dow Soars Past 48,000 as Gold and Silver Shine in a Market of Paradox
New York, NY – November 12, 2025 – In a remarkable display of market resilience and underlying tension, the Dow Jones Industrial Average (DJIA) has surged past the 48,000-point threshold, closing at an... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Dow Breaches 48,000 Milestone Amidst Government Shutdown Resolution Hopes, S&P 500 and Nasdaq Lag
The Dow Jones Industrial Average (DJIA) made history on Wednesday, November 12, 2025, surging past the 48,000-point mark for the first time ever, gaining nearly 380 points. This significant rally was... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Dow Jones Industrial Average Soars to Record High: A Nuanced Signal for the Economy
NEW YORK, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has reached an unprecedented milestone today, soaring to a new all-time high of 47,927.96, a robust gain of 559.33 points... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Dow Jones Industrial Average Soars to New All-Time High Amidst Shifting Market Dynamics
New York, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has today surged to an unprecedented all-time high, pushing past significant milestones and reinforcing a complex, yet largely... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Why Amgen Stock Was a Nearly 5% Winner Today ↗
The company continued to bask in the glow of a very solid third quarter. 
Via The Motley Fool
News headline image
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Three Healthcare Buys That Wall Street Loves ↗
These three healthcare stocks are outperforming most of the sector. 
Via The Motley Fool
News headline image
The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call
Amgen’s third quarter results were well received by the market, reflecting robust volume-driven growth across its diversified portfolio. Management credited rising demand for key medicines—including... 
Via StockStory
Topics Earnings
News headline image
Q3 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Moderna (NASDAQ:MRNA) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Cash-Producing Stocks to Research Further and 1 We Find Risky
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Topics Credit Cards
News headline image
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60% ↗
Merck said Saturday its new pill — a possible rival to Regeneron and Amgen — lowered high cholesterol by almost 60%. 
Via Investor's Business Daily
News headline image
Market Reels from Volatility and Mixed Signals: A Deep Dive into Investor Unease
The past week, from November 1st to November 8th, 2025, has witnessed a significant shift in global market sentiment, moving decisively towards a "risk-off" stance. Investors are grappling with... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Amgen Stock: New All-Time Highs Ahead After Earnings Beat ↗
Via MarketBeat
News headline image
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025.... 
Via MarketMinute
Topics Intellectual Property
News headline image
Wall Street Shakes Off Jitters as AMD and McDonald’s Impress ↗
Stronger-than-expected job data and upbeat corporate earnings pushed U.S. markets higher, despite recent warnings of an imminent correction. 
Via Chartmill
News headline image
3 Large-Cap Stocks to Consider Right Now
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
Topics Supply Chain
News headline image
Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars
The burgeoning market for obesity and diabetes treatments, particularly GLP-1 receptor agonists, is witnessing a dramatic divergence in fortunes among its leading players. As of November 5, 2025, Novo... 
Via MarketMinute
Topics Economy
News headline image
Why Amgen Stock Was Crushing It on Wednesday ↗
Its latest quarterly results were solid, thanks to strong sales of its top products. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing... 
Via Benzinga
Topics Economy
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance
Biotech company Amgen (NASDAQ:AMGN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 12.4% year on year to $9.56 billion. The company’s full-year revenue guidance of... 
Via StockStory
News headline image
These S&P500 stocks that are showing activity before the opening bell on Wednesday. ↗
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
News headline image
Amgen (NASDAQ:AMGN) Delivers Strong Q3 Numbers
Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.4% year on year to $9.56 billion. The company’s full-year revenue guidance of $36.2 billion at... 
Via StockStory
News headline image
Amgen Crushes Third-Quarter Expectations On The Back Of Two Blockbusters ↗
The biotech giant also raised its sales and adjusted earnings outlook for the year. 
Via Investor's Business Daily
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.